- Home
- CATX vs IMOS Comparison
CATX vs IMOS Comparison
Compare CATX & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- IMOS
- Stock Information
- Founded
- CATX 1983
- IMOS 1997
- Country
- CATX United States
- IMOS Taiwan
- Employees
- CATX N/A
- IMOS N/A
- Industry
- CATX Medical/Dental Instruments
- IMOS Semiconductors
- Sector
- CATX Health Care
- IMOS Technology
- Exchange
- CATX Nasdaq
- IMOS Nasdaq
- Market Cap
- CATX 782.7M
- IMOS 679.2M
- IPO Year
- CATX N/A
- IMOS N/A
- Fundamental
- Price
- CATX $3.44
- IMOS $18.49
- Analyst Decision
- CATX Strong Buy
- IMOS
- Analyst Count
- CATX 9
- IMOS 0
- Target Price
- CATX $17.25
- IMOS N/A
- AVG Volume (30 Days)
- CATX 1.2M
- IMOS 24.0K
- Earning Date
- CATX 02-12-2025
- IMOS 02-20-2025
- Dividend Yield
- CATX N/A
- IMOS 6.10%
- EPS Growth
- CATX N/A
- IMOS 7.03
- EPS
- CATX N/A
- IMOS 0.07
- Revenue
- CATX $1,557,000.00
- IMOS $724,842,895.00
- Revenue This Year
- CATX N/A
- IMOS $11.63
- Revenue Next Year
- CATX N/A
- IMOS $6.29
- P/E Ratio
- CATX N/A
- IMOS $12.75
- Revenue Growth
- CATX N/A
- IMOS 13.31
- 52 Week Low
- CATX $2.70
- IMOS $17.70
- 52 Week High
- CATX $19.10
- IMOS $32.19
- Technical
- Relative Strength Index (RSI)
- CATX 41.92
- IMOS 44.05
- Support Level
- CATX $3.02
- IMOS $17.70
- Resistance Level
- CATX $3.74
- IMOS $18.60
- Average True Range (ATR)
- CATX 0.26
- IMOS 0.34
- MACD
- CATX 0.16
- IMOS 0.01
- Stochastic Oscillator
- CATX 60.90
- IMOS 51.97
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. The Company derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.